Skin cancer is still detected using visual examination, a method of limited reliability for early detection, subtype determination, or measuring the extent of skin invasion. With the Huntsman Cancer Institute (HCI), we have validated a new device, named URSKIN, that exploits changes in the electrical properties of skin that occur during cancer cell development by using a technique called non-visual electrical impedance demography (EID).
